Related Experiment Video
Updated: Jul 17, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
A novel algorithm for complete ranking of DMUs dealing with negative data using Data Envelopment Analysis and
Hoda Dalili Yazdi1, Farzad Movahedi Sobhani1, Farhad Hosseinzadeh Lotfi2
1Department of Industrial Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.
This study introduces a new algorithm combining Principal Component Analysis and Slacks-Based Measure (PCA-SBM) to improve Data Envelopment Analysis (DEA) ranking power. The enhanced model accurately ranks all Decision Making Units (DMUs), including efficient and inefficient ones, even with negative data.
Area of Science:
- Operations Research
- Management Science
- Econometrics
Background:
- Data Envelopment Analysis (DEA) faces challenges with high input-output ratios, leading to misclassification of inefficient Decision Making Units (DMUs) as efficient.
- This limitation moderates the ranking power of traditional DEA models, necessitating improved methodologies for accurate performance evaluation.
Purpose of the Study:
- To develop and validate an algorithm that enhances the ranking power of DEA by addressing the misclassification of DMUs.
- To introduce a combined Principal Component Analysis and Slacks-Based Measure (PCA-SBM) model for improved efficiency assessment.
- To present a PCA-integrated Super-Efficiency model (PCA-Super SBM) capable of ranking both extreme and non-extreme efficient DMUs.
Main Methods:
- The study proposes an algorithm integrating Principal Component Analysis (PCA) with the Slacks-Based Measure (SBM) to reduce misclassification of efficient DMUs.
- A Super-Efficiency model is combined with PCA (PCA-Super SBM) to enable complete ranking of all DMUs, including non-extreme efficient ones.
- The developed models are demonstrated to effectively handle negative data, a limitation in previous PCA-DEA studies.
Main Results:
- The PCA-SBM model demonstrated superior ranking power compared to the standard SBM model in case studies involving pharmaceutical companies and bank branches.
- The PCA-Super SBM model successfully ranked non-extreme efficient DMUs, outperforming the standard Super SBM model in complete ranking.
- Empirical evidence from pharmaceutical companies and bank branches validates the algorithm's applicability and performance, showing significant improvements in ranking accuracy.
Conclusions:
- The proposed algorithm, utilizing PCA-SBM and PCA-Super SBM, successfully overcomes the limitations of traditional DEA models in ranking DMUs.
- The methodology provides a robust solution for complete DMU ranking, encompassing inefficient, extreme efficient, and non-extreme efficient units with low complexity.
- The models' ability to handle negative data and their superior ranking power establish their effectiveness in performance evaluation across various sectors.
More Related Videos
Related Concept Videos
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Analysis of Population Pharmacokinetic Data
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...

